Aims and Scope of Molecular Diversity
Molecular Diversity is a quarterly peer-reviewed scientific journal published by Springer Science+Business Media covering research on molecular diversity and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full-length papers, perspectives, news, and reviews. Coverage addresses the generation of molecular diversity, application of diversity for screening against alternative targets of all types, and the analysis of results and their applications. The journal was established in 1995 and the editors-in-chief are Hong-yu Li and Kunal Roy. Less
Key Metrics
CiteScore 

4.1
Impact Factor 

< 5
SJR 

Q3Catalysis

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Molecular Diversity
Molecular Diversity Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Molecular Diversity ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Molecular Diversity
Triazole-based inhibitors for breast cancer: biological activity, SAR and synthetic strategies.
- 19 May 2026
- Molecular diversity
Reusable Pd/TiO2 nanocatalyst for regiospecific sonochemical synthesis of indolizine-based chromone isosters via multicomponent reaction.
- 19 May 2026
- Molecular diversity
Integrated assessment of developmental toxicity of antibiotic pollutants: Machine learning prediction, zebrafish validation, and network toxicology.
- 19 May 2026
- Molecular diversity
Design, synthesis, anticancer estimation, and computational studies of novel benzochromenoimidazopyrimidines as CDK-2 inhibitors and apoptosis stimulators.
- 19 May 2026
- Molecular diversity
Hybrid APSO-Bayesian optimized triple-kernel SVR models for QSAR and rational design of 1H-pyrrolo[2,3-c]pyridine-based LSD1 Inhibitors.
- 14 May 2026
- Molecular diversity
Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.
- 14 May 2026
- Molecular diversity
Triazole-based inhibitors for breast cancer: biological activity, SAR and synthetic strategies.
- 19 May 2026
- Molecular diversity
Reusable Pd/TiO2 nanocatalyst for regiospecific sonochemical synthesis of indolizine-based chromone isosters via multicomponent reaction.
- 19 May 2026
- Molecular diversity
Integrated assessment of developmental toxicity of antibiotic pollutants: Machine learning prediction, zebrafish validation, and network toxicology.
- 19 May 2026
- Molecular diversity
Design, synthesis, anticancer estimation, and computational studies of novel benzochromenoimidazopyrimidines as CDK-2 inhibitors and apoptosis stimulators.
- 19 May 2026
- Molecular diversity
Hybrid APSO-Bayesian optimized triple-kernel SVR models for QSAR and rational design of 1H-pyrrolo[2,3-c]pyridine-based LSD1 Inhibitors.
- 14 May 2026
- Molecular diversity
Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents.
- 14 May 2026
- Molecular diversity